SAT0059 Criteria for Choice by Clincians of The Therapeutic Strategy in Patients with Insufficient Response To A First Anti-TNF: Data from The Randomized “Roc” Criteria
Emmanuel Chatelus(Laboratoire National de Référence), J.E. Gottenberg(Inserm), Philippe Ravaud(Inserm), Christelle Sordet, Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique)
Cited by 0
Related Papers
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Living systematic review: 1. Introduction—the why, what, when, and how
|Journal of Clinical Epidemiology|2017|676
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587